These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1887797)

  • 1. Effects of platelet-activating factor antagonist SRI 63-441 on endotoxin-induced changes in rat mesenteric microcirculation.
    Li SH; Fei X; Gong XQ; Wu ZL
    Yao Xue Xue Bao; 1991; 26(1):6-9. PubMed ID: 1887797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of platelet-activating factor on rat mesenteric microcirculation.
    Li SH; Gong XQ; Fei X; Wu ZL
    Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):344-6. PubMed ID: 2104488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of endotoxin-induced increase in glucose metabolism by platelet-activating factor antagonist.
    Lang CH; Dobrescu C; Hargrove DM; Bagby GJ; Spitzer JJ
    Circ Shock; 1987; 23(3):179-88. PubMed ID: 3427772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor.
    Sun XM; Hsueh W; Torre-Amione G
    Am J Pathol; 1990 Apr; 136(4):949-56. PubMed ID: 2327475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD; Mikulaschek AW
    Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of platelet activating factor to hemodynamic and sympathetic responses to bacterial endotoxin in conscious rats.
    Qi M; Jones SB
    Circ Shock; 1990 Oct; 32(2):153-63. PubMed ID: 2253318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441.
    Morris DD; Moore JN
    Circ Shock; 1989 Jun; 28(2):149-58. PubMed ID: 2544315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological properties of the antagonist SRI 63-441 in the PAF and endotoxin models of hypotension in the rat and dog.
    Handley DA; Van Valen RG; Tomesch JC; Melden MK; Jaffe JM; Ballard FH; Saunders RN
    Immunopharmacology; 1987 Apr; 13(2):125-32. PubMed ID: 3597060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep.
    Christman BW; Lefferts PL; Blair IA; Snapper JR
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1272-8. PubMed ID: 2174655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAF-acether and endotoxin display similar effects on rat mesenteric microvessels: inhibition by specific antagonists.
    Lagente V; Fortes ZB; Garcia-Leme J; Vargaftig BB
    J Pharmacol Exp Ther; 1988 Oct; 247(1):254-61. PubMed ID: 3171975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative hemodynamics and cardiovascular effects of endotoxin and platelet-activating factor in rat.
    Salari H; Demos M; Wong A
    Circ Shock; 1990 Nov; 32(3):189-207. PubMed ID: 2261677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of leukotriene receptor antagonists on vascular permeability during endotoxic shock.
    Cook JA; Li EJ; Spicer KM; Wise WC; Halushka PV
    Circ Shock; 1990 Nov; 32(3):209-18. PubMed ID: 2175680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of PAF-induced systemic responses in the rat, guinea pig, dog and primate by the receptor antagonist SRI 63-441.
    Handley DA; Tomesch JC; Saunders RN
    Thromb Haemost; 1986 Aug; 56(1):40-4. PubMed ID: 3775689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
    Chang SW
    J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the platelet activating factor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride on endotoxin-induced hypotension and hematological parameters in rats.
    Natsume Y; Imanishi N; Koike H; Morooka S
    Arzneimittelforschung; 1994 Nov; 44(11):1208-13. PubMed ID: 7848333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.
    Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL
    J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activating factor impairs pressor responses to noradrenaline in the anaesthetized rat but does not mediate endotoxin-induced hyporeactivity.
    Bouvier C; Guc MO; Furman BL; Parratt JR
    Circ Shock; 1994 Jan; 42(1):14-9. PubMed ID: 8149505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of dexamethasone in endotoxic shock and its relation to PAF-acether synthesis in the gastrointestinal tract and lung.
    Ibbotson GC; Wallace JL
    J Lipid Mediat; 1989; 1(5):273-82. PubMed ID: 2519897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.
    Chang SW; Feddersen CO; Henson PM; Voelkel NF
    J Clin Invest; 1987 May; 79(5):1498-509. PubMed ID: 3553241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
    Rabinovici R; Yue TL; Farhat M; Smith EF; Esser KM; Slivjak M; Feuerstein G
    J Pharmacol Exp Ther; 1990 Oct; 255(1):256-63. PubMed ID: 2213560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.